Yvette E Latchman
Silverback Therapeutics (United States) · 63 works · 7,117 citations · h-index 25
Top works
- PD-L2 is a second ligand for PD-1 and inhibits T cell activation
- Tissue expression of PD-L1 mediates peripheral T cell tolerance
- PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells
- Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
- Negative co-receptors on lymphocytes
- Identification of the 2B4 molecule as a counter-receptor for CD48.
- Programmed Death-1 (PD-1):PD-Ligand 1 Interactions Inhibit TCR-Mediated Positive Selection of Thymocytes
- Cutting Edge: Identification of the 2B4 Molecule as a Counter-Receptor for CD48
- PD‐L1 and PD‐L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis
- Association of Immunological Changes with Clinical Efficacy in Atopic Eczema Patients Treated with Traditional Chinese Herbal Therapy (Zemaphyte®)
- CD48-deficient mice have a pronounced defect in CD4 + T cell activation
- Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis
- The Efficacy of Traditional Chinese Herbal Therapy in Atopic Eczema
- Ly6Clow Monocytes Differentiate into Dendritic Cells and Cross-Tolerize T Cells through PDL-1
- PD-L1/PD-1 Signal Deficiency Promotes Allogeneic Immune Responses and Accelerates Heart Allograft Rejection
- An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression
- Nasal histamine release following hyperosmolar and allergen challenge
- Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
- T cell epitopes of the major fraction of rye grassLolium perenne (Lol pI) defined using overlapping peptidesin vitroandin vivo. I. Isoallergen clone 1A
- Leukofiltration plus pathogen reduction prevents alloimmune platelet refractoriness in a dog transfusion model